rdf:type |
|
lifeskim:mentions |
umls-concept:C0009402,
umls-concept:C0017262,
umls-concept:C0038952,
umls-concept:C0185117,
umls-concept:C0205179,
umls-concept:C0205251,
umls-concept:C0441889,
umls-concept:C0962754,
umls-concept:C1417203,
umls-concept:C1618608,
umls-concept:C2745888,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-1-6
|
pubmed:abstractText |
Extracellular matrix degradation is required for invasive growth and metastasis formation in colorectal carcinoma; therefore, we examined matrix metalloproteinases expression (MMP-1, MMP-13 and MT1-MMP) and apoptosis in tumours from 49 patients with advanced colorectal disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0030-2414
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
337-46
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14707454-Adult,
pubmed-meshheading:14707454-Aged,
pubmed-meshheading:14707454-Collagenases,
pubmed-meshheading:14707454-Colorectal Neoplasms,
pubmed-meshheading:14707454-Female,
pubmed-meshheading:14707454-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:14707454-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:14707454-Humans,
pubmed-meshheading:14707454-Male,
pubmed-meshheading:14707454-Matrix Metalloproteinase 1,
pubmed-meshheading:14707454-Matrix Metalloproteinase 13,
pubmed-meshheading:14707454-Matrix Metalloproteinases, Membrane-Associated,
pubmed-meshheading:14707454-Metalloendopeptidases,
pubmed-meshheading:14707454-Middle Aged,
pubmed-meshheading:14707454-Survival Analysis,
pubmed-meshheading:14707454-Tumor Markers, Biological
|
pubmed:year |
2003
|
pubmed:articleTitle |
Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma.
|
pubmed:affiliation |
Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland. riyben@utu.fi
|
pubmed:publicationType |
Journal Article
|